Azlocillin, a New Drug to Treat Lyme Disease
Is it possible that there may finally be a drug that might successfully treat Chronic Lyme Disease?
Jayakumar Rajadas, assistant professor of medicine and director of the Biomaterials and Advanced Drug Delivery Laboratory at the Stanford University School of Medicine says, “It [Azlocillin] clears the infection [Borrelia Burgdorferi] without a lot of side effects.”
The new findings suggest the drug azlocillin not only kills off the Borrelia burgdorferi bacteria during the initial acute stages of illness, but could also be effective for treating patients with persistent symptoms of Lyme disease.
Futurity reports that researchers, Pothineni and Rajadas have patented the compound for the treatment of Lyme disease and are working with a company to develop an oral form of the drug. Researchers plan to conduct a clinical trial.
- Potential treatment for Lyme disease kills bacteria that may cause lingering symptoms, study finds
- ANTIBIOTIC KILLS BACTERIA THAT CAUSES LYME DISEASE